EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark PLINIAD was filed as Word mark on 09/28/2010 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/26/2011.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 009407181 |
| Application date | September 28, 2010 |
| Publication date | January 17, 2011 |
| Entry date | April 26, 2011 |
| Expiration date | September 28, 2030 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics; antidepressants; pharmaceuticals; pharmaceuticals relating to anxiety spectrum disorders, atherosclerosis and/or Alzheimers; pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment and prevention of Crohns disease, systemic lupus erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the treatment and prevention of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment and prevention of autoimmune disorders
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| September 30, 2020 | Extension, Trade mark renewed | ||
| April 25, 2019 | Change Representative, Published | ||
| December 20, 2018 | Change Representative, Published |
ID: 11009407181